---
title: "Phenylpropanolamine - Allergic Conjunctivitis"
sidebar: mydoc_sidebar
permalink: db00397-mesh-d003233-1.html
toc: false 
---


Path ID: `DB00397_MESH_D003233_1`
{% include image.html url="images/db00397-mesh-d003233-1.png" file="db00397-mesh-d003233-1.png" alt="db00397-mesh-d003233-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D010665 | Phenylpropanolamine | Drug |
| UniProt:P35348 | Alpha-1A adrenergic receptor | Protein |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| GO:0070254 | Mucus secretion | BiologicalProcess |
| HP:0012393 | Allergy | PhenotypicFeature |
| MESH:D003233 | Allergic conjunctivitis | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Phenylpropanolamine | INCREASES ACTIVITY OF | Alpha-1A Adrenergic Receptor |
| Alpha-1A Adrenergic Receptor | POSITIVELY REGULATES | Vasoconstriction |
| Vasoconstriction | NEGATIVELY CORRELATED WITH | Mucus Secretion |
| Mucus Secretion | POSITIVELY CORRELATED WITH | Allergy |
| Allergy | POSITIVELY CORRELATED WITH | Allergic Conjunctivitis |
|---------|-----------|---------|

Comment: Phenylpropanolamine is a sympathomimetic that was previously used in nasal decongestants and weight loss products, but has been withdrawn by the FDA due to safety risks and lack of efficacy.

Reference: 
  - [https://go.drugbank.com/drugs/DB00397](https://go.drugbank.com/drugs/DB00397)
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL61006/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL61006/)
